Mayo Clinic Research Suggests Women Over 65 Be Offered Hereditary Cancer Genetic Testing
The study results suggest that perhaps all women with breast cancer, including those diagnosed over age 65, should be offered hereditary breast cancer testing.
Category: Cancer
Cancer
Latest
Cancer
Latest
Birmingham University, Nonacus Partner to Develop Urine Test for Bladder Cancer
The urine test, which is expected to be available by mid-2022, will use highly sensitive liquid biopsy technology developed by Nonacus and a panel of biomarkers validated by Birmingham University researchers to diagnose bladder cancer.
Cancer
Latest
Labcorp, OmniSeq Launch Insight Next-Gen Sequencing Platform for Precision Oncology
OmniSeq Insight is a pan-cancer, solid tumor test that combines two different treatment paradigms: genomic and immune profiling.
Invitae Opens Early Access to Liquid Biopsy-Based Personalized Cancer Monitoring Test
Full commercial availability of the Invitae liquid biopsy-based PCM as a laboratory-developed test is expected later this year.
Read More
Multi-Cancer Detection Blood Test Debuts
Guardian Research Network has debuted a multi-cancer early detection test able to detect more than 50 cancer types through blood draw.
Read More
Novel Urine Screening Test Can Detect New and Recurrent Bladder Cancer
A study found a new urine screening test using a novel K17 cancer biomarker can detect new bladder cancer in patients with blood in the urine.
Read More
‘Electronic Nose’ Accurately Sniffs Out Hard-to-Detect Cancers
An odor-based test that sniffs out vapors emanating from blood samples was able to distinguish cancer cells with up to 95% accuracy.
Read More
FDA Approves FoundationOne CDx for Use with Bile Duct Cancer Treatment
Truseltiq is a treatment for bile duct cancer. FoundationOne’s CDx CGP test will be used as a registrational companion diagnostic.
Read More
Veracyte to Acquire HalioDx, Positioning for Global Cancer Diagnostics Growth
After its acquisition by Veracyte, HalioDx’s operations and laboratories will remain in Marseille, France and Richmond, Va.
Read More
New Biosensor Developed to Aid Early Diagnosis of Breast Cancer
The mesoporous biosensor developed to detect breast cancer is easy to use, low cost, and provides results in a very short time—between 30 and 60 minutes—from a sample of the patient’s plasma.
Read More
Urine Protein Biomarkers May Have Diagnostic Potential
Researchers have identified urine protein biomarkers of bladder cancer. ELISA validation was used to validate the top four biomarkers.
Read More
Validation Study: Nasal Swab Test Can Significantly Improve Early Lung Cancer Detection
The new findings show the Percepta Nasal Swab, a first-of-its-kind genomic test, accurately classifies lung cancer risk in current or former smokers with lung nodules so that those with benign nodules may safely avoid unnecessary additional procedures.
Read More
Indica Labs, Ibex Partner on AI Clinical Workflows to Improve Cancer Diagnosis
Indica Labs and Ibex Medical Analytics announced an agreement to integrate the Galen AI-based cancer diagnostics platform into the HALO AP digital pathology workflow platform.
Read More
Castle Biosciences to Acquire Myriad MyPath Laboratory
Castle Biosciences’ acquisition of CLIA-certified Myriad MyPath Laboratory from Myriad Genetics will expand its suite of genomic tests for skin cancer.
Read More
“45 Is the New 50” as USPSTF Lowers Age for Colorectal Cancer Screening
Prompted by a recent alarming rise in cases of colorectal cancer in people younger than 50, an independent expert panel has recommended that individuals of average risk for the disease begin screening exams at 45 years of age instead of the traditional 50.
Read MoreWebinar: Detecting PI3K Signaling Pathway Mutations
Resistance to breast cancer therapy and disease progression may result from activation of the PI3K pathway.
Read More
Ovarian Cancer Screening Did Not Reduce Deaths
A large-scale randomized trial of annual screening for ovarian cancer did not succeed in reducing deaths from the disease, despite one of the screening methods tested detecting cancers earlier.
Read More
Gold Leaf Could Help Diagnose Viral Infections in Low-Resource Settings
Researchers developed gold leaf electrodes that, in combination with a CRISPR-based assay, could sensitively detect HPV DNA in human samples.
Read More
- 1
- ...
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- 111
- 112
- 113
- 114
- 115
- 116
- 117
- 118
- 119
- 120
- 121
- 122
- ...
- 123